{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-091055","form_type":"8-K","ticker":"ACHV","cik":"0000949858","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2025-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.915956+00:00","generated_at":"2026-05-18T17:17:13.158074+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Achieve Life Sciences prices $45M offering: 15M shares and warrants at $3.00 per unit","bullets":["Public offering of 15M shares of common stock and accompanying warrants to purchase up to 15M shares, priced at $3.00 per unit.","Gross proceeds ~$45M; net proceeds ~$41.3M after underwriting discounts and expenses; expected close June 30, 2025.","Underwriters granted 30-day option to purchase up to an additional 2.25M shares and/or warrants.","Each warrant exercisable for one share at $3.00, or exchangeable for pre-funded warrant at $0.001/share; 5-year term; 9.99% ownership cap.","Proceeds to fund cytisinicline advancement for smoking cessation through potential FDA approval and for working capital."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-091055","json":"https://secwatch.observer/filing/0000950170-25-091055.json","markdown":"https://secwatch.observer/filing/0000950170-25-091055.md","text":"https://secwatch.observer/filing/0000950170-25-091055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/949858/000095017025091055/0000950170-25-091055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/949858/000095017025091055/achv-20250626.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T17:17:13.158074+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}